July 15, 2025
New Monthly Program Explores the Science, Challenges, and Breakthroughs Behind Living Longer and Healthier Lives
July 15, 2025 – New York, NY – Bloomberg Television today announced the launch of “Longevity with David Rubenstein,” a new monthly program by the Carlyle Group Co-Founder and Co-Executive Chairman, and Bloomberg Television host David Rubenstein. The series will examine one of the most urgent and captivating questions of our time: how can we live longer – and better?
Longevity with David Rubenstein dives into the rapidly evolving world of medical research, pharmaceuticals, and science-backed wellness to uncover the facts behind the growing human pursuit of extended, healthier living. The show premieres July 22, airing at 9:00pm ET on Bloomberg TV. As innovation accelerates across medicine and wellness, distinguishing credible information from misinformation has become increasingly challenging. Longevity with David Rubenstein offers a forum for clear, evidence-based discussions to help audiences navigate a rapidly evolving health landscape.
“This series takes a closer look at the scientific and medical breakthroughs that are reshaping how we think about aging and health. What can we learn from today’s research to help us live longer — and live better?” said Rubenstein.
In each episode, Rubenstein draws on Bloomberg’s data-driven journalism to explore key issues that impact longevity – from groundbreaking therapies and drug innovations to the major health challenges still limiting lifespan, including obesity, neurodegenerative diseases, and cancer. Through conversations with leading scientists, physicians, policy experts, and more, Rubenstein offers viewers a clear, compelling view of where the science stands – and where it’s heading.
“Health and longevity are topics of growing global interest, and we believe viewers are looking for credible, intelligent coverage in this space,” said David Merritt, Head of Bloomberg Media Editorial. “With Longevity with David Rubenstein, we’re bringing audiences expert-driven insights, grounded in data and science, on one of the most compelling issues of our time.”
Longevity is Rubenstein’s third collaboration with Bloomberg Media, he is also the host of “The David Rubenstein Show: Peer to Peer Conversations” and “Bloomberg Wealth with David Rubenstein.”
David M. Rubenstein is Co-Founder and Co-Chairman of The Carlyle Group, a global investment firm. Mr. Rubenstein chairs the Council on Foreign Relations, the National Gallery of Art, the University of Chicago, and the Economic Club of Washington, D.C. He is a trustee of Memorial Sloan-Kettering Cancer Center and Johns Hopkins Medicine, as well as a Director of Moderna, Inc., among other board seats. An original signer of The Giving Pledge, Mr. Rubenstein is a leader in the area of Patriotic Philanthropy, and has been awarded the Presidential Medal of Freedom for his renowned philanthropic efforts and generous support for the restoration of historic landmarks and the country’s cultural institutions. Mr. Rubenstein is also the Chairman, CEO, and principal owner of Major League Baseball’s Baltimore Orioles.
About Bloomberg Television
Bloomberg Television is a truly global business news channel, reaching more than 400 million homes worldwide from the network’s studios in New York, London, and Hong Kong. The network provides breaking news coverage and analysis of the people, companies, and ideas that move the markets. Bloomberg TV+ is an enhanced version of Bloomberg Television that combines the power of Bloomberg data and trusted programming with a state-of-the art digital format. For more information on Bloomberg, please visit http://www.bloomberg.com/about and follow us on Twitter (@BloombergTV) and Facebook.
About Bloomberg Media
Bloomberg Media is the world’s leading multi-platform media company for business and finance, which draws on the editorial resources of more than 3,000 journalists and analysts in more than 100 bureaus around the world. Bloomberg Media is the consumer-facing media organization of Bloomberg L.P.